Short-term Changes on C-reactive Protein (CRP) Levels After Non-surgical Periodontal Treatment in Systemically Healthy Individuals

Overview

Journal Clin Oral Investig

Specialty Dentistry

Date 2016 Apr 13

PMID 27068411

Citations 17

Authors

Andre Barbisan de Souza

Rogerio T P Okawa

Cleverson O Silva

Mauricio G Araujo

Affiliations

Soon will be listed here.

Abstract

Objectives: The aim of the present study was to evaluate serum C-reactive protein (CRP) levels in chronic periodontitis patients and periodontally healthy individuals and to assess the effect of non-surgical periodontal treatment on the CRP levels.

Materials And Methods: Twenty-two patients with chronic periodontitis (test group) and 22 periodontally healthy individuals (control group), both groups without any systemic disorder or potential confounding factors, were included in the study. At baseline, periodontal clinical variables and CRP levels were obtained in both groups. In the test group, oral hygiene instruction and scaling and root planning were carried out; then, after 60 days, periodontal clinical variables and CRP levels were reevaluated.

Results: The baseline CRP level in the test group was significantly higher than the corresponding value in the control group (1.98 ± 1.55 vs. 1.26 ± 1.05 mg/L; p < 0.05). After periodontal treatment in the test group, there were improvements in all periodontal clinical variables (p < 0.05). The CRP level decreased significantly in those patients with higher baseline levels of CRP (>3 mg/L).

Conclusions: Chronic periodontitis seemed to promote elevated levels of CRP. Furthermore, non-surgical periodontal treatment significantly decreased the levels of CRP only in patients with high baseline levels of such pro-inflammatory cytokine.

Clinical Relevance: Periodontitis may be a potential factor to change the risk of CVD. Thus, the control of periodontal infection performed by health professionals may improve cardiovascular health.

Citing Articles

New Trends in the Impact of Periodontal Treatment on Early Cardiovascular Diseases Outcomes: Insights and Future Perspectives.

Amato M, Lupi S, Polizzi A, Santonocito S, Viglianisi G, Cicciu M Rev Cardiovasc Med. 2024; 24(10):287.

PMID: 39077574 PMC: 11273151. DOI: 10.31083/j.rcm2410287.

Early detection of cardiovascular risk markers through non-invasive ultrasound methodologies in periodontitis patients.

Nicolosi G, Donzella M, Polizzi A, Angjelova A, Santonocito S, Zanoli L Open Med (Wars). 2024; 19(1):20241003.

PMID: 39034949 PMC: 11260002. DOI: 10.1515/med-2024-1003.

Systemic Impact of Subgingival Infection Control in Periodontitis Patients with Cardiovascular Disease: A Narrative Review.

Caloian C, Ciurea A, Negucioiu M, Roman A, Micu I, Picos A Antibiotics (Basel). 2024; 13(4).

PMID: 38667035 PMC: 11047730. DOI: 10.3390/antibiotics13040359.

Updates on the Role of Periodontitis-Related Epigenetics, Inflammation, Oral Microbiome, and Treatment in Cardiovascular Risk.

Men B, Li Y, Jiang S J Inflamm Res. 2024; 17:837-851.

PMID: 38344306 PMC: 10859091. DOI: 10.2147/JIR.S449661.

An Update on the Interdisciplinary Dental Care Approach for Geriatric Diabetic Patients.

Surlari Z, Ciurcanu O, Budala D, Butnaru O, Luchian I Geriatrics (Basel). 2023; 8(6).

PMID: 38132485 PMC: 10743251. DOI: 10.3390/geriatrics8060114.

References

Taylor B, Tofler G, Morel-Kopp M, Carey H, Carter T, Elliott M . The effect of initial treatment of periodontitis on systemic markers of inflammation and cardiovascular risk: a randomized controlled trial. Eur J Oral Sci. 2010; 118(4):350-6. DOI: 10.1111/j.1600-0722.2010.00748.x. View

Tabet F, Rye K . High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond). 2008; 116(2):87-98. DOI: 10.1042/CS20080106. View

Fredriksson M, Figueredo C, Gustafsson A, Bergstrom K, Asman B . Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins. J Periodontol. 1999; 70(11):1355-60. DOI: 10.1902/jop.1999.70.11.1355. View

OLeary T, Drake R, Naylor J . The plaque control record. J Periodontol. 1972; 43(1):38. DOI: 10.1902/jop.1972.43.1.38. View

Ainamo J, Bay I . Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975; 25(4):229-35. View

Blake G, Ridker P . High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis. Eur Heart J. 2001; 22(5):349-52. DOI: 10.1053/euhj.2000.2280. View

Pejcic A, Kesic L, Milasin J . C-reactive protein as a systemic marker of inflammation in periodontitis. Eur J Clin Microbiol Infect Dis. 2010; 30(3):407-14. DOI: 10.1007/s10096-010-1101-1. View

Noack B, Genco R, Trevisan M, Grossi S, Zambon J, De Nardin E . Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol. 2001; 72(9):1221-7. DOI: 10.1902/jop.2000.72.9.1221. View

Mattila K, Vesanen M, Valtonen V, Nieminen M, Palosuo T, Rasi V . Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis. 2002; 2:30. PMC: 138813. DOI: 10.1186/1471-2334-2-30. View

10.

Goyal L, Bey A, Gupta N, Sharma V . Comparative evaluation of serum C-reactive protein levels in chronic and aggressive periodontitis patients and association with periodontal disease severity. Contemp Clin Dent. 2014; 5(4):484-8. PMC: 4229757. DOI: 10.4103/0976-237X.142816. View

11.

Teles R, Wang C . Mechanisms involved in the association between periodontal diseases and cardiovascular disease. Oral Dis. 2011; 17(5):450-61. PMC: 3373016. DOI: 10.1111/j.1601-0825.2010.01784.x. View

12.

Ridker P, Glynn R, Hennekens C . C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998; 97(20):2007-11. DOI: 10.1161/01.cir.97.20.2007. View

13.

Vidal F, Figueredo C, Cordovil I, Fischer R . Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol. 2009; 80(5):786-91. DOI: 10.1902/jop.2009.080471. View

14.

Khader Y, Albashaireh Z, Alomari M . Periodontal diseases and the risk of coronary heart and cerebrovascular diseases: a meta-analysis. J Periodontol. 2004; 75(8):1046-53. DOI: 10.1902/jop.2004.75.8.1046. View

15.

Buhlin K, Gustafsson A, Pockley A, Frostegard J, Klinge B . Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J. 2003; 24(23):2099-107. DOI: 10.1016/j.ehj.2003.09.016. View

16.

Gomes-Filho I, Coelho J, Cruz S, Passos J, Freitas C, Aragao Farias N . Chronic periodontitis and C-reactive protein levels. J Periodontol. 2010; 82(7):969-78. DOI: 10.1902/jop.2010.100511. View

17.

Marcaccini A, Meschiari C, Sorgi C, Saraiva M, de Souza A, Faccioli L . Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol. 2009; 80(4):594-602. DOI: 10.1902/jop.2009.080561. View

18.

Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

19.

DAiuto F, Orlandi M, Gunsolley J . Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Clin Periodontol. 2013; 40 Suppl 14:S85-105. DOI: 10.1111/jcpe.12061. View

20.

Gorska R, Nedzi-Gora M . The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis. Arch Immunol Ther Exp (Warsz). 2006; 54(6):419-26. DOI: 10.1007/s00005-006-0047-6. View